These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4976938)

  • 1. Quantitative studies of immunofluorescent staining. 3. Comparison of different antigens in an indirect immunofluorescent staining system for human IgG using the basement zone antibodies of bullous pemphigoid.
    Wick G; Beutner EH
    Immunology; 1969 Feb; 16(2):149-56. PubMed ID: 4976938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorescent studies in mucous membrane pemphigoid.
    Griffith MR; Fukuyama K; Tuffanelli D; Silverman S
    Arch Dermatol; 1974 Feb; 109(2):195-9. PubMed ID: 4205499
    [No Abstract]   [Full Text] [Related]  

  • 3. Cicatricial pemphigoid. Immunofluorescent studies.
    Bean SF
    Arch Dermatol; 1974 Oct; 110(4):552-5. PubMed ID: 4212995
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlative study of rubella antibody titre, basement zone antibody titre, and IgG content of sera of patients with bullous pemphigoid.
    Remy W; Bockendahl H; Antoniadis G
    Acta Derm Venereol; 1974; 54(6):449-51. PubMed ID: 4140659
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum from normal elderly individuals contains anti-basement membrane zone antibodies.
    Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y
    Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid in childhood. Immunofluorescent studies.
    Fincher DF; Dupree E; Bean SF
    Arch Dermatol; 1971 Jan; 103(1):88-90. PubMed ID: 4923970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-skin antibodies and immunoglobulins in pemphigus and bullous pemphigoid].
    Yamaguchi S
    Igaku Kenkyu; 1971 Sep; 41(6):521-37. PubMed ID: 4946877
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors contributing to occasional failures in the laboratory diagnosis of bullous pemphigoid by indirect immunofluorescence.
    Chorzelski TP; Beutner EH
    Br J Dermatol; 1972 Feb; 86(2):110-7. PubMed ID: 4622781
    [No Abstract]   [Full Text] [Related]  

  • 9. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating autoantibodies in ocular pemphigoid.
    Waltman SR; Yarian D
    Am J Ophthalmol; 1974 Jun; 77(6):891-4. PubMed ID: 4209155
    [No Abstract]   [Full Text] [Related]  

  • 11. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone.
    Satoh S; Seishima M; Izumi T; Ito A; Kamiya H; Kitajima Y
    Br J Dermatol; 1997 Nov; 137(5):768-73. PubMed ID: 9415239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in bullous diseases. Immunofluorescent serologic tests.
    Peck SM; Osserman KE; Weiner LB; Lefkovits A; Osserman RS
    N Engl J Med; 1968 Oct; 279(18):951-8. PubMed ID: 4300571
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects of immunofluorescent diagnostics in bullous skin diseases. II. Pemphigoid and Duhring's disease].
    Chorzelski T; Maciejowska E; Jarzabek M
    Przegl Dermatol; 1971; 58(3):343-7. PubMed ID: 4944034
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunopathology of pemphigus and bullous pemphigoid.
    Beutner EH; Jordon RE; Chorzelski TP
    J Invest Dermatol; 1968 Aug; 51(2):63-80. PubMed ID: 4897477
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration of basement membrane autoantibodies in patients with benign mucous membrane pemphigoid.
    Dabelsteen E; Ullman S; Thomsen K; Rygaard J
    Acta Derm Venereol; 1974; 54(3):189-92. PubMed ID: 4134127
    [No Abstract]   [Full Text] [Related]  

  • 17. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in bullous pemphigoid.
    Muller HK; Sutherland RC; Jamieson WJ; De Boer WG
    Med J Aust; 1971 Feb; 1(8):429-31. PubMed ID: 4928304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.